This antibody is provided in phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 50% glycerol.
Preparation:
The antibody was purified by Protein A affinity chromatography.
Storage & Handling:
Upon receipt, store frozen at -20° C.
Application:
WB, IF
Recommended Usage:
Each lot of this antibody is quality control tested by Western blotting. Western blotting, suggested working dilution(s): Use 10 μl per 5 ml antibody dilution buffer for each mini-gel. For immunofluorescence microscopy: Use a dilution range of 1:100~1:400. It is recommended that the reagent be titrated for optimal performance for each application.
Hela cell extract was resolved by electrophoresis, transferred to nitrocellulose, and probed with rabbit anti-Galectin 3 antibody. Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system.
Description:
Galectin 3 (also known as galactose-specific lectin 3 and Mac-2 antigen) is a 32 kD member of the galaptin (S-lectin) family, BH-1, that contains carbohydrate recognition domains. This protein forms homo- and hetero-dimers and localizes to the nucleus or cytoplasm depending on proliferation state. Galectin 3 has been shown to modulate allergic reactions and regulate mRNA splicing activity, cell cycle control, and cell adhesion. The expression of galectin 3 can be increased by acetylated LDL, oxidized LDL, and Runx2. Galectin 3 can be modified by phosphorylation and acetylation and has been shown to interact with IgE, galactose, casein kinase I, laminin, mucin, β-galactoside residues of cell surface, matrix glycoproteins, and some intracellular proteins. The Poly6132 antibody recognizes human and mouse galectin 3 and has been shown to be useful for Western blotting.
IgE, galactose, casein kinase I, laminin, mucin, β-galactoside residues of cell surface, matrix glycoproteins, intracellular proteins
Antigen References:
1. Huflejt, M., et al., 1993. J. Biol. Chem. 268:26712. 2. Lotz, M., et al., 1993. PNAS 90:3466. 3. Iacobini, C., et al., 2003. J. Am. Soc. Nephrol. 14:S264. 4. Takenaka, Y., et al., 2003. Cancer Lett. 195:111. 5. Liang, G., et al. 2008. Hum Mol Genet. 17:3254. PubMed
